Hard to know, given the confidentiality, but the Merck deal might underpin the current company valuation all by itself.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025